E-LIB Suche - Ergebnisse für: Simon Heuking

1

Down selecting adjuvanted vaccine formulations: a comparati..:

Younis, Sumera Y. ; Barnier-Quer, Christophe ; Heuking, Simon...
BMC Immunology. 19 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

2

Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR..:

Poecheim, Johanna ; Heuking, Simon ; Brunner, Livia...
Nanomaterials. 5 (2015) 4 - p. 2317-2334 , 2015

Link: https://doi.org/10.3390/..

3

Targeted Nasal Vaccination Provides Antibody-Independent Pr..:

Misstear, Karen ; McNeela, Edel A. ; Murphy, Alison G....
The Journal of Infectious Diseases. 209 (2014) 9 - p. 1479-1484 , 2014

Link: http://www.jstor.org/sta..

4

Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticl..:

Heuking, Simon ; Rothen-Rutishauser, Barbara ; Raemy, David Olivier..
Journal of Nanobiotechnology. 11 (2013) 1 - p. , 2013

Link: https://doi.org/10.1186/..

5

Targeted Nasal Vaccination Provides Antibody-Independent Pr..:

Misstear, Karen ; McNeela, Edel A. ; Murphy, Alison G....
The Journal of Infectious Diseases. 209 (2013) 9 - p. 1479-1484 , 2013

Link: https://doi.org/10.1093/..

6

Multifunctional PLGA-Based Nanoparticles Encapsulating Simu..:

Primard, Charlotte ; Poecheim, Johanna ; Heuking, Simon...
Molecular Pharmaceutics. 10 (2013) 8 - p. 2996-3004 , 2013

Link: https://doi.org/10.1021/..

7

Toll-Like Receptor-7 Agonist Decoration Enhances the Adjuva..:

Heuking, Simon ; Borchard, Gerrit
Journal of Pharmaceutical Sciences. 101 (2012) 3 - p. 1166-1177 , 2012

Link: https://doi.org/10.1002/..

8

Down selecting adjuvanted vaccine formulations: a comparati..:

Sumera Y. Younis ; Christophe Barnier-Quer ; Simon Heuking...
http://link.springer.com/article/10.1186/s12865-018-0245-0. , 2018

Link: https://doi.org/10.1186/..

9

Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR..:

Johanna Poecheim ; Simon Heuking ; Livia Brunner...
https://dx.doi.org/10.3390/nano5042317. , 2015

Link: https://doi.org/10.3390/..

10

Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR..:

Johanna Poecheim ; Simon Heuking ; Livia Brunner...
http://www.mdpi.com/2079-4991/5/4/2317. , 2015

Link: https://doi.org/10.3390/..

11

Down selecting adjuvanted vaccine formulations: a comparati..:

Younis, Sumera Y ; Barnier-Quer, Christophe ; Heuking, Simon...
info:eu-repo/grantAgreement/EC/FP7/228403/. , 2018

Link: https://zenodo.org/recor..

12

Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR..:

Poecheim, Johanna ; Heuking, Simon ; Brunner, Livia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304807/. , 2015

Link: http://www.ncbi.nlm.nih...

13

Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR..:

Poecheim, Johanna ; Heuking, Simon ; Brunner, Livia...
info:eu-repo/semantics/altIdentifier/doi/10.3390/nano5042317. , 2015

Link: https://archive-ouverte...

14

Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticl..:

Heuking, Simon ; Rothen-Rutishauser, Barbara ; Raemy, David..
http://www.jnanobiotechnology.com/content/11/1/29. , 2013

Link: http://www.jnanobiotechn..

15

Targeted Nasal Vaccination Provides Antibody-Independent Pr..:

Misstear, Karen ; McNeela, Edel A ; Murphy, Alison G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813749/. , 2013

Link: http://www.ncbi.nlm.nih...